Add-on prednisolone ‘still has role in RA’
A trial shows it can be useful to dampen disease activity while maintaining an acceptable safety profile, researchers say.
A trial shows it can be useful to dampen disease activity while maintaining an acceptable safety profile, researchers say.
History: A fit 80-year-old retired teacher woke up with a painful right wrist that prevented him from writing or holding a cup of coffee. He…
An Australian-developed genetic risk score could provide a 'personalised' approach to managing osteoarthritis.
Patients who fail to respond to vaccination could benefit from a 'timely' monoclonal antibody combination, a French study suggests.
Scientists are looking at repurposing existing treatments as well as new agents targeting fatigue and inflammation.
Analysis of survival among a large British cohort suggests, however, that mortality is not increased in these patients.
Much more research is needed, however, to establish causality, US researchers say.
Those receiving iberdomide were more prone to discontinuation, infections and neutropenia.
Dr Alex Klestov's family hopes to raise enough funds to ensure his patients in Central and South-East Queensland have access to rheumatology servic…
Addition of leflunomide to methotrexate therapy may be valuable for patients with active disease, researchers say.
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.